The ArtixASCEND Study
ConditionAcute Lower Limb Arterial Occlusion
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInari Medical
About this trial
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Acute symptom duration ≤ 14 days
Lower limb arterial occlusion below inguinal ligament
Target lesion in native vessel
Disqualifiers
Life expectancy < 6 months
Prior major amputation in the target limb
Prior minor amputation in the target limb that is not completely healed or cannot bear weight
Non-thrombotic occlusion secondary to dissection, vasculitis, or target vessel trauma
Trial design
Treatments tested in this trial
- Artix Thrombectomy System
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov